Logotherapy and Cognitive Reframing in the Management of Blame Attribution Among Cancer Patients

Abstract

This study ascertained how Cognitive Reframing (CR) and Logotherapy (LT) affected how recently diagnosed cancer patients managed their assigning of blame. A quasi-experimental pretest-posttest control group design was used in the study. For screening, the Blame Attribution Questionnaire (α=0.81) was employed. Fifty-four cancer patients were chosen based on their high Blame Attribution Screening score. The subjects were divided into three groups at random: control (15), CR (21), and LT (18). Descriptive statistics, analysis of covariance, and multiple classification analysis post-hoc test at the 0.05 significance level were used to analyze the data. The average age of the participants was 53.85±7.89 years, with 88.9% being female. Breast cancer (53.7%), cervical cancer (33.3%), prostate cancer (9.3%), and skin cancer (3.7%) are the cancer types that participants suffer from. The participants' attribution of blame was significantly affected by the treatment (F(2;42) = 16.03; partial = 0.43). More people benefited from the CR (x ̅ = 42.91) than from the LT (x ̅ = 63.56) or the control (x ̅ = 66.87) groups. In newly diagnosed cancer patients, blame attribution was effectively managed with the help of logotherapy and cognitive reframing. These therapies should be used by clinical psychologists and counselors to manage blame attribution in newly diagnosed cancer patients.